FDA 483 - Jaglowski, Samantha - February 14, 2018

The FDA inspected Sterling Loving Hall in Columbus, OH, a clinical investigator. The inspection revealed that the firm failed to conduct an investigation in accordance with its investigational plan. Specifically, protocol-specified procedures for vital signs and chemistry panel laboratory evaluations were not performed for multiple subjects.